Measles seroprevalence of an adolescent population vaccinated with a single dose of measles vaccine before their first birthday.
This study determined the age-specific measles seroprevalence of an adolescent population in Ankara vaccinated with a single dose of measles vaccine before their first birthday. The study sample included 440 adolescents (227 female, 213 male) aged 9-16 years admitted to the Adolescent Outpatient Clinic of Hacettepe University Faculty of Medicine. For each participant, a questionnaire was completed and measles specific IgG antibodies screened quantitatively by the enzyme linked immunosorbent assay. Of the 440 subjects screened for measles antibodies, 114 (25.9 %) were seronegative. Measles seronegativity according to sex and age groups were, 32.6, 24.7, 13.3% in females and 29.5, 30.1, 6.3% in males in the age groups of 9-11, 12-14, 15-16 years, respectively. In countries where the two dose vaccination schedule against measles has not been incorporated to the national immunization program, the adolescent health maintenance visit at age 11-12 years should serve as an opportunity to evaluate vaccination status and administer MMR vaccine to all adolescents who have not received two doses at the recommended ages.
Kanbur
Nuray Oksüz
NO
Section of Adolescent Medicine, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey. nuraykanbur@hotmail.com
Derman
Orhan
O
Kutluk
Tezer
T
D000293:Adolescent; D000367:Age Factors; D002648:Child; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000592:standards*; D007115:Immunization Schedule; D007223:Infant; D008297:Male; D008457:Measles / Q000097:blood / Q000453:epidemiology* / Q000517:prevention & control; D008458:Measles Vaccine / Q000008:administration & dosage*; D008459:Measles virus / Q000276:immunology; D016036:Seroepidemiologic Studies; D011795:Surveys and Questionnaires; D013997:Time Factors; D014421:Turkey / Q000453:epidemiology
D008458:Measles Vaccine